BioStock: The market in Saudi Arabia opens up for Chordate

Report this content

Medtech company Chordate Medical has recently received an order for the rhinitis treatment from the private healthcare company Nahdi Care Clinics in Saudi Arabia. The company expects more orders for the product system, both from private and publicly owned hospitals. In addition, the company’s distributor, Janin Medical, is working to obtain market authorisation for Chordate’s migraine treatment.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/05/the-market-in-saudi-arabia-opens-up-for-chordate/

This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se

Subscribe

Documents & Links

Quick facts

BioStock: The market in Saudi Arabia opens up for Chordate
Tweet this